Table 1.
Adherence Rates to Established Quality Indicators (Seattle Protocol, Surveillance) and potential metrics (Dysplasia detection rate)
| Endoscopist Adherence Rates to Seattle Biopsy Protocol | |||
|---|---|---|---|
| EGD Volume | Number of endoscopists | Mean Adherence Rate (SD) | 25th / 50th / 75th Percentile |
| 10–19 | 230 | 83.3% (23.2) | 76.9% / 92.3% / 100% |
| 20–29 | 146 | 85.6% (17.5) | 80.0% / 92.0% / 100% |
| ≥30 | 196 | 86.8% (22.3) | 83.9% / 96.5% / 100% |
| Endoscopist Adherence Rates to Appropriate 3–5 year Surveillance in NDBE | |||
| 10–14 | 129 | 66.6% (SD 33.8) | 50.0% / 80.0% / 91.7% |
| 15–24 | 151 | 75.5% (26.3) | 64.7% / 84.2% / 94.4% |
| ≥25 | 120 | 69.8% (29.6) | 55.2% / 80.6% / 92.5% |
| Site Adherence Rates to Seattle Biopsy Protocol | |||
| EGD Volume | Number of sites | Mean Adherence Rate (SD) | 25th / 50th / 75th Percentile |
| 20–49 | 43 | 76.0% (26.8) | 61.5% / 90.0% / 95.8% |
| 50–99 | 40 | 77.3% (26.4) | 73.3% / 87.2% / 97.0% |
| 100–149 | 23 | 86.7% (15.6) | 84.4% / 90.8% / 96.4% |
| ≥150 | 47 | 88.1% (15.6) | 82.7% / 94.2% / 97.6% |
| Site Adherence Rates to Appropriate 3–5 year Surveillance in NDBE | |||
| 20–29 | 29 | 68.8% (28.6) | 56.0% / 78.6% / 90.5% |
| 30–49 | 32 | 65.1% (23.9) | 52.7% / 69.4% / 83.6% |
| 50–99 | 37 | 67.6% (27.1) | 63.2% / 76.4% / 86.3% |
| ≥100 | 38 | 73.3% (23.1) | 63.9% / 81.1% / 89.9% |
| Endoscopist Dysplasia Detection Rate | |||
| EGD Volume | Number of endoscopists/sites | DDR Mean (SD) Range | LGD and HGD (SD) Range |
| 10–19 | 230 | 3.28% (6.11) 0–38.46% |
1.78% (4.13) 0–30% |
| 20–29 | 145 | 3.92% (5.12) 0–22.73% |
2.23% (3.63) 0–17.24% |
| ≥30 | 197 | 2.91% (4.08) 0–23.53% |
1.47% (2.35) 0–13.33% |
| Site Dysplasia Detection Rate by volume of endoscopies | |||
| 20–49 | 42 | 3.32% (3.69) 0–13.33% |
2.23% (2.72) 0–10% |
| 50–99 | 40 | 4.01% (4.90) 0–23.73% |
2.15% (2.59) 0–12% |
| 100–149 | 23 | 2.16% (1.55) 0–6% |
1.18% (1.10) 0–3.5% |
| ≥150 | 47 | 3.34% (3.11) 0–13.33% |
1.7% (1.45) 0–6.31% |